Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fletcher

Showing results (1351-1360 of 1,501) with videos related to

Pageof 151
Sort By:
Cancer Cell|March 7, 2003
Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classificationScott A Armstrong, Andrew L Kung, Meghann E Mabon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumorsJayesh Desai, Sridhar Shankar, Michael C Heinrich, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 13, 2016
Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell lineYvonne de Jong, Annemiek M van Maldegem, Adrian Marino-Enriquez, et al.
Clinical and Vaccine Immunology : CVI|July 14, 2017
The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014Michael J Brennan, Rachel Tanner, Sheldon Morris, et al.
Prostate Cancer and Prostatic Diseases|September 2, 2018
Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancerMarieke J Krimphove, Alexander P Cole, Sean A Fletcher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 8, 2020
Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic AreasDavid J Blok, Joseph Kamgno, Sebastien D Pion, et al.
British Journal of Cancer|July 3, 2008
Heterogeneity and clinical significance of ETV1 translocations in human prostate cancerG Attard, J Clark, L Ambroisine, et al.
Annals of Surgical Oncology|May 17, 2012
Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: identification of aurora kinase A as a poor risk markerChueh-Chuan Yen, Chun-Nan Yeh, Chi-Tung Cheng, et al.
Clinical and Vaccine Immunology : CVI|August 30, 2013
Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCGHelen A Fletcher, Rachel Tanner, Robert S Wallis, et al.
NPJ Vaccines|January 5, 2021
A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidatesRachel Tanner, Andrew D White, Charelle Boot, et al.
Pageof 151

Showing results (1351-1360 of 1,501) with videos related to

Sort By:
Pageof 151
Cancer Cell|March 7, 2003
Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classificationScott A Armstrong, Andrew L Kung, Meghann E Mabon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumorsJayesh Desai, Sridhar Shankar, Michael C Heinrich, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 13, 2016
Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell lineYvonne de Jong, Annemiek M van Maldegem, Adrian Marino-Enriquez, et al.
Clinical and Vaccine Immunology : CVI|July 14, 2017
The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014Michael J Brennan, Rachel Tanner, Sheldon Morris, et al.
Prostate Cancer and Prostatic Diseases|September 2, 2018
Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancerMarieke J Krimphove, Alexander P Cole, Sean A Fletcher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 8, 2020
Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic AreasDavid J Blok, Joseph Kamgno, Sebastien D Pion, et al.
British Journal of Cancer|July 3, 2008
Heterogeneity and clinical significance of ETV1 translocations in human prostate cancerG Attard, J Clark, L Ambroisine, et al.
Annals of Surgical Oncology|May 17, 2012
Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: identification of aurora kinase A as a poor risk markerChueh-Chuan Yen, Chun-Nan Yeh, Chi-Tung Cheng, et al.
Clinical and Vaccine Immunology : CVI|August 30, 2013
Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCGHelen A Fletcher, Rachel Tanner, Robert S Wallis, et al.
NPJ Vaccines|January 5, 2021
A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidatesRachel Tanner, Andrew D White, Charelle Boot, et al.
Pageof 151